HEADER HYDROLASE 11-JUL-06 2IXV TITLE CRYSTAL STRUCTURE OF THE MODULAR CPL-1 ENDOLYSIN COMPLEXED WITH A TITLE 2 PEPTIDOGLYCAN ANALOGUE (E94Q MUTANT) COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYSOZYME; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CPL-1, ENDOLYSIN, MURAMIDASE, CP-1 LYSIN; COMPND 5 EC: 3.2.1.17; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOCOCCUS PHAGE CP-1; SOURCE 3 ORGANISM_COMMON: CP-1 BACTERIOPHAGE; SOURCE 4 ORGANISM_TAXID: 10747; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI DH1; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 536056 KEYWDS ANTIMICROBIAL, MUEIN HYDROLASE, BACTERIOLYTIC ENZYME, PNEUMOCOCCAL KEYWDS 2 CELL WALL DEGRADATION, LYSOZYME, HYDROLASE, GLYCOSIDASE, KEYWDS 3 MULTIMODULAR EXPDTA X-RAY DIFFRACTION AUTHOR I.PEREZ-DORADO,J.A.HERMOSO REVDAT 7 13-DEC-23 2IXV 1 HETSYN LINK REVDAT 6 29-JUL-20 2IXV 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE ATOM REVDAT 5 01-JUL-20 2IXV 1 COMPND REMARK HET HETNAM REVDAT 5 2 1 FORMUL LINK SITE ATOM REVDAT 4 10-APR-19 2IXV 1 SOURCE LINK REVDAT 3 24-FEB-09 2IXV 1 VERSN REVDAT 2 28-AUG-07 2IXV 1 JRNL REVDAT 1 03-JUL-07 2IXV 0 JRNL AUTH I.PEREZ-DORADO,N.E.CAMPILLO,B.MONTERROSO,D.HESEK,M.LEE, JRNL AUTH 2 J.A.PAEZ,P.GARCIA,M.MARTINEZ-RIPOLL,J.L.GARCIA,S.MOBASHERY, JRNL AUTH 3 M.MENENDEZ,J.A.HERMOSO JRNL TITL ELUCIDATION OF THE MOLECULAR RECOGNITION OF BACTERIAL CELL JRNL TITL 2 WALL BY MODULAR PNEUMOCOCCAL PHAGE ENDOLYSIN CPL-1. JRNL REF J.BIOL.CHEM. V. 282 24990 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17581815 JRNL DOI 10.1074/JBC.M704317200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.A.HERMOSO,B.MONTERROSO,A.ALBERT,B.GALAN,O.AHRAZEM, REMARK 1 AUTH 2 P.GARCIA,M.MARTINEZ-RIPOLL,J.L.GARCIA,M.MENENDEZ REMARK 1 TITL STRUCTURAL BASIS FOR SELECTIVE RECOGNITION OF PNEUMOCOCCAL REMARK 1 TITL 2 CELL WALL BY MODULAR ENDOLYSIN FROM PHAGE CP-1 REMARK 1 REF STRUCTURE (LONDON) V. 11 1 2003 REMARK 1 REFN ISSN 0969-2126 REMARK 1 PMID 14527392 REMARK 1 DOI 10.1016/J.STR.2003.09.005 REMARK 1 REFERENCE 2 REMARK 1 AUTH B.MONTERROSO,A.ALBERT,M.MARTINEZ-RIPOLL,P.GARCIA,J.L.GARCIA, REMARK 1 AUTH 2 M.MENENDEZ,J.A.HERMOSO REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY DIFFRACTION STUDIES OF REMARK 1 TITL 2 THE COMPLETE MODULAR ENDOLYSIN FROM CP-1, A PHAGE INFECTING REMARK 1 TITL 3 STREPTOCOCCUS PNEUMONIAE REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 58 1487 2002 REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 12198311 REMARK 1 DOI 10.1107/S0907444902011563 REMARK 2 REMARK 2 RESOLUTION. 1.96 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.96 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1734679.420 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 35314 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2490 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.96 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.08 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5410 REMARK 3 BIN R VALUE (WORKING SET) : 0.2790 REMARK 3 BIN FREE R VALUE : 0.3030 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 441 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2763 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 270 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.87000 REMARK 3 B22 (A**2) : -3.23000 REMARK 3 B33 (A**2) : -0.64000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.20 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.710 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.420 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.240 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.040 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.040 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 50.38 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2IXV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-JUL-06. REMARK 100 THE DEPOSITION ID IS D_1290029224. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUL-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE MONOCROMATOR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40900 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.960 REMARK 200 RESOLUTION RANGE LOW (A) : 26.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1H09 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.53650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.53650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 39.98250 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 48.22150 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 39.98250 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 48.22150 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 63.53650 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 39.98250 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 48.22150 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 63.53650 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 39.98250 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 48.22150 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLU 94 TO GLN REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 5 -0.69 71.78 REMARK 500 SER A 38 -142.25 55.92 REMARK 500 GLN A 94 10.74 -142.45 REMARK 500 SER A 126 -174.20 176.15 REMARK 500 ASP A 193 90.28 -40.07 REMARK 500 THR A 198 77.75 59.65 REMARK 500 LYS A 288 -108.08 60.49 REMARK 500 ASN A 296 24.20 -141.78 REMARK 500 THR A 318 -5.95 -59.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 770 DISTANCE = 5.98 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 10-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 11-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1H09 RELATED DB: PDB REMARK 900 MULTIMODULAR PNEUMOCOCCAL CELL WALL ENDOLYSIN FROM PHAGE CP-1 REMARK 900 RELATED ID: 1OBA RELATED DB: PDB REMARK 900 MULTIMODULAR PNEUMOCOCCAL CELL WALL ENDOLYSIN FROM PHAGE CP-1 REMARK 900 COMPLEXED WITH CHOLINE REMARK 900 RELATED ID: 2IXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MODULAR CPL-1 ENDOLYSIN COMPLEXED WITH A REMARK 900 PEPTIDOGLYCAN ANALOGUE (WILD-TYPE ENDOLYSIN) DBREF 2IXV A 1 339 UNP P15057 LYS_BPCP1 1 339 SEQADV 2IXV GLN A 94 UNP P15057 GLU 94 ENGINEERED MUTATION SEQRES 1 A 339 MET VAL LYS LYS ASN ASP LEU PHE VAL ASP VAL SER SER SEQRES 2 A 339 HIS ASN GLY TYR ASP ILE THR GLY ILE LEU GLU GLN MET SEQRES 3 A 339 GLY THR THR ASN THR ILE ILE LYS ILE SER GLU SER THR SEQRES 4 A 339 THR TYR LEU ASN PRO CYS LEU SER ALA GLN VAL GLU GLN SEQRES 5 A 339 SER ASN PRO ILE GLY PHE TYR HIS PHE ALA ARG PHE GLY SEQRES 6 A 339 GLY ASP VAL ALA GLU ALA GLU ARG GLU ALA GLN PHE PHE SEQRES 7 A 339 LEU ASP ASN VAL PRO MET GLN VAL LYS TYR LEU VAL LEU SEQRES 8 A 339 ASP TYR GLN ASP ASP PRO SER GLY ASP ALA GLN ALA ASN SEQRES 9 A 339 THR ASN ALA CYS LEU ARG PHE MET GLN MET ILE ALA ASP SEQRES 10 A 339 ALA GLY TYR LYS PRO ILE TYR TYR SER TYR LYS PRO PHE SEQRES 11 A 339 THR HIS ASP ASN VAL ASP TYR GLN GLN ILE LEU ALA GLN SEQRES 12 A 339 PHE PRO ASN SER LEU TRP ILE ALA GLY TYR GLY LEU ASN SEQRES 13 A 339 ASP GLY THR ALA ASN PHE GLU TYR PHE PRO SER MET ASP SEQRES 14 A 339 GLY ILE ARG TRP TRP GLN TYR SER SER ASN PRO PHE ASP SEQRES 15 A 339 LYS ASN ILE VAL LEU LEU ASP ASP GLU GLU ASP ASP LYS SEQRES 16 A 339 PRO LYS THR ALA GLY THR TRP LYS GLN ASP SER LYS GLY SEQRES 17 A 339 TRP TRP PHE ARG ARG ASN ASN GLY SER PHE PRO TYR ASN SEQRES 18 A 339 LYS TRP GLU LYS ILE GLY GLY VAL TRP TYR TYR PHE ASP SEQRES 19 A 339 SER LYS GLY TYR CYS LEU THR SER GLU TRP LEU LYS ASP SEQRES 20 A 339 ASN GLU LYS TRP TYR TYR LEU LYS ASP ASN GLY ALA MET SEQRES 21 A 339 ALA THR GLY TRP VAL LEU VAL GLY SER GLU TRP TYR TYR SEQRES 22 A 339 MET ASP ASP SER GLY ALA MET VAL THR GLY TRP VAL LYS SEQRES 23 A 339 TYR LYS ASN ASN TRP TYR TYR MET THR ASN GLU ARG GLY SEQRES 24 A 339 ASN MET VAL SER ASN GLU PHE ILE LYS SER GLY LYS GLY SEQRES 25 A 339 TRP TYR PHE MET ASN THR ASN GLY GLU LEU ALA ASP ASN SEQRES 26 A 339 PRO SER PHE THR LYS GLU PRO ASP GLY LEU ILE THR VAL SEQRES 27 A 339 ALA HET MUB B 1 19 HET NAG B 2 14 HET FMT A 401 3 HET ALA A 404 5 HET DGN A 405 10 HETNAM MUB N-ACETYL-ALPHA-MURAMIC ACID HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FMT FORMIC ACID HETNAM ALA ALANINE HETNAM DGN D-GLUTAMINE HETSYN MUB N-ACETYL-MURAMIC ACID; N-ACETYLMURAMIC ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 MUB C11 H19 N O8 FORMUL 2 NAG C8 H15 N O6 FORMUL 3 FMT C H2 O2 FORMUL 4 ALA C3 H7 N O2 FORMUL 5 DGN C5 H10 N2 O3 FORMUL 6 HOH *270(H2 O) HELIX 1 1 SER A 12 GLY A 16 5 5 HELIX 2 2 ILE A 19 GLY A 27 1 9 HELIX 3 3 CYS A 45 GLN A 52 1 8 HELIX 4 4 ASP A 67 ASN A 81 1 15 HELIX 5 5 ASP A 100 ALA A 118 1 19 HELIX 6 6 LYS A 128 VAL A 135 1 8 HELIX 7 7 ASP A 136 PHE A 144 1 9 HELIX 8 8 ASN A 161 PHE A 165 5 5 HELIX 9 9 ASN A 296 ASN A 300 5 5 SHEET 1 AA11 LEU A 7 VAL A 11 0 SHEET 2 AA11 ASP A 182 VAL A 186 -1 O ASP A 182 N ASP A 10 SHEET 3 AA11 ILE A 171 SER A 177 -1 O TRP A 174 N ILE A 185 SHEET 4 AA11 LEU A 148 ALA A 151 1 O LEU A 148 N ARG A 172 SHEET 5 AA11 LYS A 121 TYR A 127 1 O TYR A 124 N TRP A 149 SHEET 6 AA11 TYR A 88 ASP A 92 1 O LEU A 89 N ILE A 123 SHEET 7 AA11 ASN A 54 PHE A 61 1 O ILE A 56 N TYR A 88 SHEET 8 AA11 ASN A 30 GLU A 37 1 O THR A 31 N ILE A 56 SHEET 9 AA11 LEU A 7 VAL A 11 1 O VAL A 9 N ILE A 32 SHEET 10 AA11 ASP A 182 VAL A 186 -1 O ASP A 182 N ASP A 10 SHEET 11 AA11 LEU A 7 VAL A 11 -1 O PHE A 8 N ASN A 184 SHEET 1 AB 2 GLY A 200 GLN A 204 0 SHEET 2 AB 2 TRP A 209 ARG A 213 -1 O TRP A 210 N LYS A 203 SHEET 1 AC 2 LYS A 222 ILE A 226 0 SHEET 2 AC 2 VAL A 229 PHE A 233 -1 O VAL A 229 N ILE A 226 SHEET 1 AD 2 GLU A 243 ASP A 247 0 SHEET 2 AD 2 LYS A 250 LEU A 254 -1 O LYS A 250 N ASP A 247 SHEET 1 AE 2 GLY A 263 VAL A 267 0 SHEET 2 AE 2 GLU A 270 MET A 274 -1 O GLU A 270 N VAL A 267 SHEET 1 AF 5 GLY A 312 PHE A 315 0 SHEET 2 AF 5 VAL A 302 SER A 309 -1 O ILE A 307 N TYR A 314 SHEET 3 AF 5 ASN A 290 THR A 295 -1 O TRP A 291 N PHE A 306 SHEET 4 AF 5 GLY A 283 TYR A 287 -1 O GLY A 283 N MET A 294 SHEET 5 AF 5 LEU A 335 THR A 337 1 O LEU A 335 N LYS A 286 LINK C ALA A 404 N DGN A 405 1555 1555 1.34 LINK N ALA A 404 C10 MUB B 1 1555 1555 1.34 LINK O4 MUB B 1 C1 NAG B 2 1555 1555 1.39 CISPEP 1 ASN A 179 PRO A 180 0 0.38 CRYST1 79.965 96.443 127.073 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012505 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010369 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007869 0.00000